glutathione cisplatin Molecular mechanisms of resistance. GSH, reduced glutathione; Emerging targets in cancer drug
Description
McGowan, Catherine White et al
Submit your comments here: To view or add a comment, sign in This would put the burden of meeting compounded GLP-1 demand on 503A pharmacies, who are not permitted to compound in bulk
KBP$
Andreeff M , Beck J, Darzynkiewicz ZD, Traganos F, Gupta S, Melamed MR, Good RA
Ligand Noninnocence in -Diketiminate and -Diketimine Copper Complexes
